| Articles Reviewed |
| 1: | J B Leverenz et al. A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. 2007 |
| 2: | Nathalie Brouwers et al. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. 2007 |
| 3: | Véronique Dorval et al. Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. 2006 |
| 4: | I-Hsuan Liu et al. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation. 2005 |
| 5: | Jee Young Sung et al. Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases. 2005 |
| 6: | Heather Snyder et al. beta-Synuclein reduces proteasomal inhibition by alpha-synuclein but not gamma-synuclein. 2005 |
| 7: | Wenbo Zhou et al. DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. 2005 |
| 8: | Eyal Avraham et al. Glycogen synthase kinase 3beta modulates synphilin-1 ubiquitylation and cellular inclusion formation by SIAH: implications for proteasomal function and Lewy body formation. 2005 |
| 9: | Leonard Petrucelli et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. 2004 |
| 10: | Atsushi Iwata et al. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies. 2003 |
| 11: | Eunsung Junn et al. Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. 2003 |
| 12: | Jill A Morris et al. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. 2003 |
| 13: | Tiebing Liang et al. alpha-Synuclein maps to a quantitative trait locus for alcohol preference and is differentially expressed in alcohol-preferring and -nonpreferring rats. 2003 |
| 14: | Michael G Schlossmacher et al. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. 2002 |
| 15: | Ruth G Perez et al. A role for alpha-synuclein in the regulation of dopamine biosynthesis. 2002 |
| 16: | He-Jin Lee et al. Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. 2002 |
| 17: | He-Jin Lee et al. Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors. 2002 |
| 18: | Eunsung Junn et al. Parkin accumulation in aggresomes due to proteasome impairment. 2002 |
| 19: | M Hashimoto et al. beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. 2001 |
| 20: | N Sharma et al. A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study. 2001 |